GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance ...Middle East

PR Newswire - News
GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance
YONGIN, South Korea and AUSTIN, Texas, Aug. 30 2022 /PRNewswire/ -- GC Biopharma (006280.KS) and Speragen today announced that a joint Externally Led - Patient-Focused Drug Development (EL-PFDD) meeting hosted by SSADH Association and attended by the U.S. FDA and other stakeholders was...

Read More Details
Finally We wish PressBee provided you with enough information of ( GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance )

Also on site :